Brand Name:

Co-Biosopt^®

Dosage:

2 % , 0.5 %

Generic Name:

Dorzolamide / Timolol

Pharmacotherapeutic Group:

Antiglaucoma agent

Therapeutic Indication:

Dorzolamide / Timolol: Co-Biosopt is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers.

Dosage and Administration:

The dose is one drop of Co-Biosopt in the affected eye(s) two times daily.

Side Effects:

• Cardiovascular: Angina, Bradyarrhythmia, Heart failure, Hypertension, Hypotension
• Gastrointestinal: Nausea, Taste sense altered, Vomiting, Xerostomia
• Neurologic: Dizziness, Headache
• Ophthalmic: Blepharitis, Blurred vision, Burning sensation in eye, Conjunctival hyperemia, Excessive tear production, Itching of eye, Light intolerance, Pain in eye
• Psychiatric: Depression
• Respiratory: Bronchitis, Dyspnea, Nasal congestion, Upper respiratory infection